First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors or Relapse/Refractory Lymphoma
Clinical trial NCT05607498 · RECRUITING
Trial details
- NCT number
- NCT05607498
- Sponsor
- EpimAb Biotherapeutics (Suzhou)Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2025-10-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.